scholarly journals Long-Term Follow-Up of Two Siblings with a Non-Classic Infantile Variant Form of Pompe Disease

2015 ◽  
Vol 2 (s1) ◽  
pp. S70-S71
Author(s):  
R. Taurisano ◽  
A. D'Amico ◽  
G.S. Colafati ◽  
A. Pichiecchio ◽  
M. Catteruccia ◽  
...  
2018 ◽  
Vol 41 (6) ◽  
pp. 1205-1214 ◽  
Author(s):  
Jan C. van der Meijden ◽  
Michelle E. Kruijshaar ◽  
Laurike Harlaar ◽  
Dimitris Rizopoulos ◽  
Nadine A. M. E. van der Beek ◽  
...  

2017 ◽  
Vol 264 (3) ◽  
pp. 589-590 ◽  
Author(s):  
Matteo Garibaldi ◽  
Sabrina Sacconi ◽  
Giovanni Antonini ◽  
Claude Desnuelle

2009 ◽  
Vol 19 (2) ◽  
pp. 113-117 ◽  
Author(s):  
N.A.M.E. Van der Beek ◽  
M.L.C. Hagemans ◽  
A.J.J. Reuser ◽  
W.C.J. Hop ◽  
A.T. Van der Ploeg ◽  
...  

2020 ◽  
Vol 6 (3) ◽  
pp. 72 ◽  
Author(s):  
Elizabeth G. Ames ◽  
Rachel Fisher ◽  
Mary Kleyn ◽  
Ayesha Ahmad

Two lysosomal storage disorders (LSDs), Pompe disease and Mucopolysaccharidosis type I (MPSI) were added to the Recommended Uniform Screening Panel (RUSP) for newborn screening (NBS) in 2015 and 2016, respectively. These conditions are being screened with variable practice in terms of primary and reflex analytes (either biochemical or molecular testing) as well as collection of short- and long-term follow-up elements. The goal of this study is to evaluate practices of state health departments in regards to screening methods and follow-up data collected. We conducted online surveys and phone questionnaires to determine each U.S. state’s practices for screening and follow-up of positive newborn screens. We report the first snapshot of practices for NBS for the LSDs included on the RUSP. All 50 U.S. states responded to our survey. The majority of U.S. states are not currently screening for Pompe disease and MPSI as of March 2020, but this number will increase to 38 states in the coming 1–3 years based on survey results. Our survey identifies data elements used by state health departments for short-and long-term follow-up that could serve as the basis of common elements for larger, public health-based analyses of the benefits and efficacy of screening for Pompe disease and MPSI.


2007 ◽  
Vol 17 (9-10) ◽  
pp. 698-706 ◽  
Author(s):  
Wolfgang Müller-Felber ◽  
Rita Horvath ◽  
Klaus Gempel ◽  
Teodor Podskarbi ◽  
Yoon Shin ◽  
...  

2013 ◽  
Vol 108 (2) ◽  
pp. S29-S30
Author(s):  
Yin-Hsiu Chien ◽  
Wuh-Liang Hwu ◽  
Ni-Chung Lee ◽  
Chun-An Chen ◽  
Fuu-Jen Tsai ◽  
...  

2010 ◽  
Vol 33 (S3) ◽  
pp. 389-393 ◽  
Author(s):  
Monica Del Rizzo ◽  
Marina Fanin ◽  
Alessia Cerutti ◽  
Chiara Cazzorla ◽  
Ornella Milanesi ◽  
...  

2007 ◽  
Vol 17 (9-10) ◽  
pp. 794 ◽  
Author(s):  
N. Van der Beek ◽  
M. Hagemans ◽  
A. Reuser ◽  
W. Hop ◽  
A. van der Ploeg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document